EF
HRMY icon

Empowered Funds’s Harmony Biosciences HRMY Stock Holding History

Empowered Funds’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.17M Buy
114,538
+4,163
+4% +$131K 0.02% 789
2026
Q1 		$3.09M Buy
+110,375
New +$3.62M 0.02% 862
2025
Q4 		– Sell
-54,271
Closed -$1.5M – 1406
2025
Q3 		$1.5M Sell
54,271
-10,746
-17% -$370K 0.02% 1037
2025
Q2 		$2.05M Sell
65,017
-5,171
-7% -$166K 0.02% 808
2025
Q1 		$2.33M Buy
+70,188
New +$2.52M 0.03% 677

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Empowered Funds's HRMY Position: Q2 2026 in Review

Empowered Funds increased its Harmony Biosciences (HRMY) stake by 3.8% in Q2 2026, buying an estimated $131K and bringing the position to 114,538 shares worth $4.17M. The position accounts for 0.02% of the portfolio, ranked #789.

Empowered Funds first reported a position in HRMY in Q1 2025 and has held it in 5 quarters since. 328 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Empowered Funds held 114,538 shares of Harmony Biosciences worth $4.17M as of Q2 2026.
  • Empowered Funds bought 4,163 Harmony Biosciences shares in Q2 2026, an estimated $131K.
  • Harmony Biosciences made up 0.02% of Empowered Funds's portfolio in Q2 2026, its #789 holding.
  • Empowered Funds first reported a position in Harmony Biosciences in Q1 2025 and has held it in 5 quarters since.
  • 328 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.